TP53 and colon carcinoma: The trans-isomer also showed stronger efficacy in Hep3B and much stronger efficacy in both colon carcinoma cell lines compared to the cis-isomer and induced more cell death in HCT-116 and especially in p53-deleted HCT-116/p53(−/−) cells compared to 10 μM SAHA.